# Climedo Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/climedo-health

- Industry: Software
- Headquarters: Munich, Germany
- Website: www.climedo.de
- Total disclosed funding: $5.8M
- Latest round: Seed (Oct 27, 2021)
- Investors on record: 3

## About

Climedo Health GmbH is a leading provider of an integrated eClinical platform that enhances the management of clinical data for pharmaceutical and biotech studies, facilitating effective communication and real-time insights.Founded in 2017, Climedo Health GmbH operates out of Munich, Germany, providing innovative solutions for clinical research management. The company was established by Dragan Mileski, Maximilian Winzlmeier, Sascha Ritz, and Veronika Schweighart. Sascha Ritz currently serves as the CEO. Climedo has completed 4 funding deals, with the most recent occurring on October 27, 2021, when it raised EUR 5 million in SEED funding from lead investor Nauta Capital, alongside W3Capital and returning investor WestTech Ventures. The total amount raised by the company is EUR 5 million, with a current valuation of EUR 34.876 mn.Climedo Health GmbH specializes in offering an integrated eClinical platform that streamlines the collection and management of clinical data for pharmaceutical and biotech studies. Their core product suite includes Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (eCOA/ePRO), electronic Case Report Forms (eCRF), and electronic consent (eConsent) solutions, which enhance communication with medical professionals and provide real-time insights into study progress. The platform supports non-interventional studies and the collection of Real-World Evidence (RWE) from Phase I-IV clinical trials, addressing challenges in data quality and participant engagement. Their solutions are utilized by contract research organizations (CROs), hospitals, and research institutions across Europe, particularly in Germany, France, and the United Kingdom.Climedo generates revenue through a subscription-based model, providing access to its eClinical solutions for CROs, pharmaceutical companies, and medical research institutions. Clients enter into service agreements allowing them to utilize various features of the platform tailored to their study requirements. Pricing tiers correspond to project scale and complexity, offering flexibility to clients. The EDC system and eCOA tools form the backbone of Climedo's revenue stream, which combines subscription fees with potential usage-based charges, ensuring steady income while supporting a growing volume of clinical studies and surveys.Following its most recent funding round in October 2021, where Climedo Health GmbH raised EUR 5 million in SEED funding, the company plans to utilize this capital to expand its presence within Europe and further develop its software solutions. The focus will be on enhancing product offerings and entering new markets as part of its growth strategy.

## Funding rounds

- Seed, Oct 27, 2021, $5.8M — Nauta Capital, WestTech Ventures, W3Capital

## Investors

- Nauta Capital (https://capitalatlas.ai/funds/nauta-capital) — Seed
- WestTech Ventures (https://capitalatlas.ai/funds/westtech-ventures) — Seed
- W3Capital (https://capitalatlas.ai/funds/w3capital) — Seed